C. Baisch

发表

CYP2C19*17 is associated with decreased breast cancer risk

H. Brauch, C. Justenhoven, U. Hamann, 2009, Breast Cancer Research and Treatment.

Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy

R. Eils, J. Chang-Claude, H. Brauch, 2010, International journal of cancer.

Polymorphisms in the UBC 9 and PIAS 3 genes of the SUMO-conjugating system and breast cancer risk

H. Brauch, C. Justenhoven, U. Hamann, 2019 .

Polymorphisms in the UBC9 and PIAS3 genes of the SUMO-conjugating system and breast cancer risk

H. Brauch, C. Justenhoven, U. Hamann, 2010, Breast Cancer Research and Treatment.

Factors Modifying the Association Between Hormone-Replacement Therapy and Breast Cancer Risk

H. Brauch, C. Justenhoven, U. Hamann, 2005, European Journal of Epidemiology.

Breast cancer: a candidate gene approach across the estrogen metabolic pathway

K. Ickstadt, R. Eils, T. Illig, 2007, Breast Cancer Research and Treatment.

The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant

M. Beckmann, P. Fasching, Jingmei Li, 2011, Breast Cancer Research and Treatment.

Postmenopausal estrogen monotherapy–associated breast cancer risk is modified by CYP17A1_-34_T>C polymorphism

R. Eils, J. Chang-Claude, H. Brauch, 2010, Breast Cancer Research and Treatment.

No association of polymorphisms in the cell polarity gene SCRIB with breast cancer risk

H. Brauch, C. Justenhoven, U. Hamann, 2011, Breast Cancer Research and Treatment.

Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women

R. Eils, J. Chang-Claude, H. Brauch, 2010, Breast Cancer Research and Treatment.

Common variants in the UBC9 gene encoding the SUMO‐conjugating enzyme are associated with breast tumor grade

H. Brauch, C. Justenhoven, U. Hamann, 2009, International journal of cancer.

Polymorphisms in circadian genes, night work and breast cancer: Results from the GENICA study

H. Brauch, C. Justenhoven, U. Hamann, 2014, Chronobiology international.

Exploring the association between genetic variation in the SUMO isopeptidase gene USPL1 and breast cancer through integration of data from the population‐based GENICA study and external genetic databases

Thomas Brüning, Beate Pesch, Ute Hamann, 2013, International journal of cancer.

The CYP1B1_1358_GG genotype is associated with estrogen receptor-negative breast cancer

T. Illig, H. Brauch, C. Justenhoven, 2008, Breast Cancer Research and Treatment.

ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population.

Thomas Brüning, Beate Pesch, Ute Hamann, 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Night work and breast cancer estrogen receptor status--results from the German GENICA study.

H. Brauch, C. Justenhoven, U. Hamann, 2013, Scandinavian journal of work, environment & health.

Night work and breast cancer - results from the German GENICA study.

K. Straif, H. Brauch, C. Justenhoven, 2010, Scandinavian journal of work, environment & health.

Polymorphic loci of E2F2, CCND1 and CCND3 are associated with HER2 status of breast tumors

T. Illig, H. Brauch, C. Justenhoven, 2009, International journal of cancer.

Investigation of Genetic Variants of Genes of the Hemochromatosis Pathway and Their Role in Breast Cancer

H. Brauch, C. Justenhoven, U. Hamann, 2005, Cancer Epidemiology Biomarkers & Prevention.

CYP2B6*6 is associated with increased breast cancer risk

Thomas Brüning, Beate Pesch, Ute Hamann, 2014, International journal of cancer.

No association of polymorphisms in the cell polarity gene with breast cancer risk

H. Brauch, U. Hamann, Y. Ko, 2020 .

Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant

Jingmei Li, P. Hall, K. Humphreys, 2013, Breast Cancer Research and Treatment.

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

Jaana M. Hartikainen, Kristen S Purrington, Ali Amin Al Olama, 2014, Human molecular genetics.

Confirmation of the reduction of hormone replacement therapy- 1 related breast cancer risk for carriers of the HSD17B1 _937_G 2 variant 3

K. Humphreys, G. Severi, M. Southey, 2013 .

The earwax-associated SNP c.538G>A (G180R) in ABCC11 is not associated with breast cancer risk in Europeans

H. Brauch, C. Justenhoven, U. Hamann, 2011, Breast Cancer Research and Treatment.